NCT00402558: Alloreactive NK Cells for Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) |
|
|
| Completed | 1 | 15 | US | Thymoglobulin, ATG, Antithymocyte globulin, Busulfan, Busulfex, Myleran®, Fludarabine, Fludarabine Phosphate, Fludara, Alloreactive NK Infusion, G-CSF, Filgrastim, Neupogen, Tacrolimus, Prograf, Methotrexate, Interleukin-2, Aldesleukin, IL-2, Proleukin | M.D. Anderson Cancer Center | Myelodysplastic Syndrome, Leukemia | 04/14 | 04/14 | | |
NCT01471067: Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies |
|
|
| Completed | 1 | 33 | US | Melphalan, Alkeran, Fludarabine, Fludarabine Phosphate, Fludara, Mycophenolate mofetil, MMF, CellCept, Tacrolimus, Prograf, Cord Blood Infusion, blood and bone marrow transplantation, Rituximab, Rituxan, ATG, Antithymocyte Globulin, Thymoglobulin, Busulfan, Bu, Myleran, Busulfex, Clofarabine, Clofarex, Clolar, Total Body Irradiation (TBI), XRT | M.D. Anderson Cancer Center, American Stem Cell, Inc., National Cancer Institute (NCI) | Blood And Marrow Transplantation, Leukemia, Lymphoma, Transplantation Infection, Transplantation, Bone Marrow | 04/17 | 04/17 | | |
